During the past decade, Oncology Hematology Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Associates" #1 sponsor was "Amgen" with 3 trials, followed by "Aadi Bioscience, Inc." with 1 trials sponsored, "MediMergent, LLC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "SecuraBio" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates" are "Chemotherapy-induced Thrombocytopenia" (2 trials), "Metastatic Cancer" (2 trials), "Solid Tumor" (2 trials), "Advanced Cancer" (1 trials) and "Advanced Solid Tumor" (1 trials). Many other conditions were trialed in "Oncology Hematology Associates" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Associates" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Romiplostim" (2 trials), "AMG 510" (1 trials), "Avelumab (MSB0010718C)" (1 trials) and "Axitinib (AG-013736)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Oncology Hematology Associates". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncology Hematology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".